16Jun
Diligence Clauses and the Management of Uncertainty in Life Sciences Agreements
In times of uncertainty and disruption, setting expectations for performance with business partners and contractual counterparties can be more complicated than ever. Companies that develop drugs, biologics and medical devices have considerable...
By:
Skadden, Arps, Slate, Meagher & Flom LLP
Related
We are hearing about a budget pinch from many homebuilder and general contractor clients tied to the...
Read More >
COVID-19 is obviously having drastic effects on all aspects of life, and the construction industry i...
Read More >
Amending standard forms of construction and engineering contracts to change the risk level between t...
Read More >
The New Jersey Department of Labor and Workforce Development earlier this month released the report ...
Read More >
'Whistleblower' is a widely used term. However, what it means and the protections a whistleblower mi...
Read More >
Day 2 of the 2019 ILG National Conference in Milwaukee started with a favorite guest – EEOC Commiss...
Read More >